Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kocabas, Fatih  [Clear All Filters]
2023
Meric N, Albayrak E, Gulbas Z, Kocabas F. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Leuk Lymphoma. 2023:1-12.
Meric N, Kocabas F. Primary Human Leukemia Stem Cell (LSC) Isolation and Characterization. Methods Mol Biol. 2023.
Albayrak E, Kocabas F. Therapeutic targeting and HSC proliferation by small molecules and biologicals. Adv Protein Chem Struct Biol. 2023;135:425-496.
2022
Albayrak E, Akgol S, Turan RDilek, Uslu M, Kocabas F. BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability. J Cell Biochem. 2022.
Uslu M, Albayrak E, Kocabas F. Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content. Int Immunopharmacol. 2022;110:109035.
Meric N, Kocabas F. The Historical Relationship Between Meis1 and Leukemia. Adv Exp Med Biol. 2022.
2018
Aksoz M, Albayrak E, Aslan GServet, Turan RDilek, Alyazici LYazgi, Siyah P, Tusuz ECan, Canikyan S, Yucel D, Meric N, et al. c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression. Curr Cancer Drug Targets. 2018.
2015
Rimmelé P, Liang R, Bigarella CL, Kocabas F, Xie J, Serasinghe MN, Chipuk J, Sadek H, Zhang CCheng, Ghaffari S. Mitochondrial metabolism in hematopoietic stem cells requires functional FOXO3. EMBO Rep. 2015.